Oscar Health, Inc.
OSCR
$13.15
$0.534.20%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 25.43M | 28.95M | 18.15M | -53.59M | -270.73M |
| Total Depreciation and Amortization | 32.15M | 30.65M | 32.35M | 33.57M | 30.69M |
| Total Amortization of Deferred Charges | 778.00K | 778.00K | 778.00K | 778.00K | 778.00K |
| Total Other Non-Cash Items | 80.98M | 100.27M | 101.13M | 105.27M | 159.18M |
| Change in Net Operating Assets | 838.86M | 767.60M | 126.71M | -138.54M | -192.09M |
| Cash from Operations | 978.19M | 928.24M | 279.12M | -52.51M | -272.16M |
| Capital Expenditure | -27.90M | -27.18M | -26.09M | -24.15M | -25.58M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.36B | -1.16B | -354.34M | 165.24M | 602.76M |
| Cash from Investing | -1.39B | -1.18B | -380.44M | 141.09M | 577.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 68.39M | 65.64M | 49.40M | 33.25M | 6.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 68.39M | 65.64M | 49.40M | 33.25M | 6.45M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -340.85M | -189.63M | -51.92M | 121.83M | 311.47M |